findmyKOL
Clinical trialNCT00401388CompletedPhase 2Interventional

A Trial of Perifosine in Patients With Chemo-Insensitive Sarcomas

SponsorAEterna ZentarisEnrollment72Alveolar Soft Part SarcomasChondrosarcomasExtra Skeletal Myxoid Chondrosarcomas
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Nov 2006
Primary completion
31 Jan 2011
Completion
31 Oct 2011
Last update posted
7 Mar 2018
Registered enrollment
72
Registry id
NCT00401388

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.